Skip to content

C-flex Hydrophilic Acrylic Injectable IOL 570C (REF 570C/+20.5)Recalls & reported problems

Rayner Intraocular Lenses Limited · Class 3 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 05029867802744), received between Nov 30, 2022 and Nov 30, 2022 — classified as 1 malfunction.

The most frequently reported specific device problem is “Material Opacification” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Material Opacification1

Patient problems

  • Visual Impairment1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionNov 30, 2022Material Opacification; Material Opacification

    ON 17TH NOVEMBER 2022, RAYNER RECEIVED NOTIFICATION FROM A US HEALTHCARE FACILITY OF AN EVENT THAT OCCURRED FOLLOWING IMPLANTATION OF A C-FLEX 570C IOL. THE EVENT DESCRIPTION PROVIDED STATES THAT POST-OPERATIVELY THE ONSET OF IOL OPACIFICATION HAS BEEN OBSERVED LEADING TO EXPLANTATION OF THE IOL.

    Patient problems: Visual Impairment

    MAUDE report 15885744 ↗

Other Intraocular Lens devices

All Intraocular Lens devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page